| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
25,766 |
20,733 |
$1.39M |
| 99442 |
|
20,128 |
16,242 |
$998K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,583 |
21,984 |
$828K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
26,653 |
21,518 |
$571K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
13,819 |
10,883 |
$393K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
35,332 |
28,590 |
$352K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,990 |
2,847 |
$291K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,895 |
4,259 |
$281K |
| 99407 |
|
13,761 |
12,520 |
$264K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
22,252 |
18,045 |
$257K |
| 99205 |
Prolong outpt/office vis |
2,992 |
2,989 |
$245K |
| 99385 |
|
1,522 |
1,521 |
$155K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
7,404 |
6,061 |
$150K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,849 |
1,775 |
$133K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
8,527 |
7,969 |
$133K |
| 94760 |
|
16,343 |
15,216 |
$88K |
| 1126F |
|
360 |
360 |
$72K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,624 |
3,295 |
$62K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,139 |
982 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,103 |
978 |
$59K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
874 |
743 |
$48K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,030 |
883 |
$44K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
947 |
937 |
$42K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
5,471 |
4,503 |
$32K |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
3,063 |
2,454 |
$28K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
576 |
478 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
481 |
445 |
$19K |
| 1125F |
|
36,535 |
28,818 |
$18K |
| 99350 |
Prolong home eval add 15m |
242 |
241 |
$16K |
| 99386 |
|
309 |
308 |
$16K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
355 |
352 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
324 |
290 |
$11K |
| 76706 |
|
124 |
124 |
$10K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
156 |
156 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
374 |
326 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,138 |
1,028 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
68 |
68 |
$5K |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
242 |
241 |
$5K |
| 88142 |
|
262 |
262 |
$4K |
| 99422 |
|
1,068 |
782 |
$4K |
| 99451 |
|
262 |
227 |
$4K |
| 76881 |
|
65 |
61 |
$3K |
| 99490 |
Ccm add 20min |
44 |
44 |
$2K |
| 93978 |
|
12 |
12 |
$2K |
| 88141 |
|
190 |
189 |
$2K |
| 99384 |
|
29 |
29 |
$2K |
| 99383 |
|
32 |
32 |
$2K |
| 93000 |
|
55 |
53 |
$1K |
| 99483 |
Prolong outpt/office vis |
32 |
28 |
$988.42 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
374 |
369 |
$954.38 |
| 87110 |
|
53 |
53 |
$890.24 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
42 |
41 |
$445.88 |
| 0013A |
|
14 |
14 |
$430.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
443 |
441 |
$360.00 |
| 76882 |
|
13 |
12 |
$311.88 |
| 0001A |
|
13 |
13 |
$220.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
134 |
134 |
$172.85 |
| 92551 |
|
15 |
15 |
$153.36 |
| 90715 |
|
13 |
13 |
$115.83 |
| 99496 |
|
57 |
54 |
$106.01 |
| 99401 |
|
144 |
116 |
$45.58 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
70 |
59 |
$18.00 |
| 1159F |
|
38,873 |
30,856 |
$0.01 |
| 3080F |
|
1,789 |
1,744 |
$0.00 |
| 3079F |
|
2,899 |
2,823 |
$0.00 |
| 3075F |
|
1,349 |
1,318 |
$0.00 |
| 0545F |
|
8,961 |
6,980 |
$0.00 |
| 1170F |
|
480 |
479 |
$0.00 |
| 3008F |
|
12,625 |
11,912 |
$0.00 |
| 3074F |
|
9,746 |
9,257 |
$0.00 |
| G0443 |
Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes |
319 |
301 |
$0.00 |
| 1157F |
|
480 |
479 |
$0.00 |
| 3044F |
|
176 |
176 |
$0.00 |
| S0612 |
Annual gynecological examination, established patient |
53 |
53 |
$0.00 |
| 1111F |
|
75 |
71 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
17 |
17 |
$0.00 |
| 3725F |
|
18,898 |
15,368 |
$0.00 |
| G9920 |
Screening performed and negative |
254 |
219 |
$0.00 |
| 1160F |
|
482 |
481 |
$0.00 |
| 3078F |
|
7,249 |
6,911 |
$0.00 |
| 3077F |
|
643 |
618 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
73 |
73 |
$0.00 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
187 |
187 |
$0.00 |